Aktieanalys

Scibase: Positive news from the US - Redeye

{newsItem.title}

Redeye Publicerad: 04 Apr 2023 09:20

Redeye views positively the news that two Medicare Administrative Contractors (MACs) have updated their fee schedules for Scibase’s early detection test for melanoma. The company has long awaited this and gives a welcome push in the ongoing US expansion.

Länk till analysen i sin helhet: https://www.redeye.se/research/892439/scibase-positive-news-from-the-us?utm_source=finwire&utm_medium=RSS

Nyheter om Scibase

Läses av andra just nu

Om aktien Scibase

Senaste nytt